Department of Anesthesiology and Pain Medicine, School of Medicine, Ewha Womans University, Seoul, Korea.
Korean J Anesthesiol. 2010 Dec;59 Suppl(Suppl):S154-7. doi: 10.4097/kjae.2010.59.S.S154. Epub 2010 Dec 31.
The ex utero intrapartum treatment (EXIT) procedure is a very rare technique performed in cases of fetal congenital malformations. The EXIT procedure increases the rate of survival at delivery by maintaining the uteroplacental circulation until the airway of the fetus is secured. To maintain the uteroplacental circulation, a higher dose of inhalational anesthetics and/or intravenous nitroglycerin can be used as compared to conventional Cesarean section. The aim of this report is to share our anesthetic experience during the EXIT procedure with members of the Korean society of anesthesiology for the first time, and to highlight the maternal implications of the use of inhalational anesthetics and nitroglycerin during Cesarean section for the EXIT procedure.
子宫外产时治疗（EXIT）程序是一种非常罕见的技术，用于治疗胎儿先天性畸形。EXIT 程序通过维持胎盘循环，直到胎儿的气道得到保障，从而提高分娩时的存活率。与传统剖宫产相比，为了维持胎盘循环，可以使用更高剂量的吸入性麻醉剂和/或静脉注射硝酸甘油。本报告的目的是首次与韩国麻醉学会的成员分享我们在 EXIT 程序中的麻醉经验，并强调在 EXIT 程序中使用吸入性麻醉剂和硝酸甘油进行剖宫产对产妇的影响。
